Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (7639)	2/29/2000 4:20:00 PM
From: Pseudo Biologist	Read Replies (1) \| Respond to of 9719

Novalon pointers: sciencemag.org pnas.org Links should not require password, but if they fail, do a medline search on Fowlkes DM. For example, this sounds relevant, though IBM is only giving me a title: patents.ibm.com This is a bit better: patents.ibm.com The present invention is directed to the identification of compounds in a compound library which can mediate the biological activity of a target receptor protein, even when the ligands which mediate that activity through binding to that receptor are not already known. The method comprises three steps: (1) Screen at least one potential surrogate combinatorial library for members (preferably peptides or nucleic acids) binding to the target protein(TP) and hence capable of use as surrogates for the unknown ligand in steps (2) and (3). (2) Screen at least one complementary library, preferably a combinatorial library (which is not limited to, and may not even include, peptides, or nucleic acids and hence is referred to on occasion as a "compound library"), for compounds which inhibit the binding of one or more surrogates from step (1) to TP, and, optionally, (3) determine whether the inhibitory compound mediates the biological activity of the said TP. Old peptide versus antibody story. Maybe DGI (NBSC) is clear of this. Perkin Elmer PE? As in PE Celera? Wow. PB